Clinical trial · Observational
Development of a Model to Predict the Risk of Venous Thromboembolic Events in Patients With Metastatic Bronchopulmonary Cancer
Développement d'un modèle prédictif du Risque de Survenue d'évènements Thromboemboliques Veineux Chez Les Patients Atteints de Cancer Broncho-pulmonaire métastatique
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Venous thrombo-embolism (VTE) is a frequent and serious complication of cancer. However, predictive tools for VTE in cancer patients is lacking. In patients with metastatic broncho-pulmonarycancer, biochemical characteristics might help to identify patients at high risk for VTE. The aim of this study is to derive a predictive score combining clinical and biochemical variable that predict VTE in metastatic broncho-pulmonary cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastatic Bronchopulmonary Cancer | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- venous thromboembolism at 12 months
- timeFrame
- 12 months
- description
- objectively diagnosed VTE based on validated diagnostic tests
Secondary outcomes (3)
- measure
- overall survival
- timeFrame
- one year
- description
- overall survival
- measure
- survival without progression
- timeFrame
- one year
- description
- survival without progression
- measure
- VTE at 6 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * metastatic broncho-pulmonary cancer * age ≥18 years * who are eligible for chemotherapy * non opposition obtained Exclusion Criteria: * age \<18 years * pregnancy, breast feeding * VTE in the past 6 months or at the time of cancer diagnosis * surgery in the past 3 months * refusal to participate
References
Publications (0)
Data not yet available